| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.005 |
| mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.01 |
| mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.01 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.01 |
| mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.02 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.03 |
| mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.03 |
| mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.03 |
| mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |